AN 2718
Alternative Names: AN-2718Latest Information Update: 13 Oct 2015
At a glance
- Originator Anacor Pharmaceuticals
- Class Antifungals; Organic boron compounds; Small molecules
- Mechanism of Action Leucyl-tRNA synthetase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Candidiasis; Mycoses; Onychomycosis; Tinea